APA (7th ed.) Citation

Hou, X., Meng, F., Wang, J., Sha, W., Chiu, C., Chung, W. C., . . . Zhang, S. (2020). 995 PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF VONOPRAZAN 20 MG VERSUS LANSOPRAZOLE 30 MG IN THE TREATMENT OF ENDOSCOPICALLY CONFIRMED DUODENAL ULCERS IN ASIAN SUBJECTS WITH OR WITHOUT HELICOBACTER PYLORI INFECTION. Gastroenterology (New York, N.Y. 1943), 158(6), S-197-S-198. https://doi.org/10.1016/S0016-5085(20)31177-X

Chicago Style (17th ed.) Citation

Hou, Xiao-hua, et al. "995 PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF VONOPRAZAN 20 MG VERSUS LANSOPRAZOLE 30 MG IN THE TREATMENT OF ENDOSCOPICALLY CONFIRMED DUODENAL ULCERS IN ASIAN SUBJECTS WITH OR WITHOUT HELICOBACTER PYLORI INFECTION." Gastroenterology (New York, N.Y. 1943) 158, no. 6 (2020): S-197-S-198. https://doi.org/10.1016/S0016-5085(20)31177-X.

MLA (9th ed.) Citation

Hou, Xiao-hua, et al. "995 PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF VONOPRAZAN 20 MG VERSUS LANSOPRAZOLE 30 MG IN THE TREATMENT OF ENDOSCOPICALLY CONFIRMED DUODENAL ULCERS IN ASIAN SUBJECTS WITH OR WITHOUT HELICOBACTER PYLORI INFECTION." Gastroenterology (New York, N.Y. 1943), vol. 158, no. 6, 2020, pp. S-197-S-198, https://doi.org/10.1016/S0016-5085(20)31177-X.